Pfizer announced Monday that it would spend $120 million to expand U.S. manufacturing of its oral COVID-19 antiviral pill at its Michigan facility.
Use of Pfizer’s Paxlovid pill in treatment of newly infected cases has risen even as the U.S. Centers for Disease Control and Prevention (CDC) warned the pill can lead to a rebound in symptoms.
“If you take Paxlovid, you might get symptoms again,” CDC Director Dr. Rochelle Walensky told CBS News on May 31. “We haven’t yet seen anybody who has returned with symptoms needing to go to the hospital. So, generally, a milder course.”
The possibility of quarantine even after taking the Paxlovid pill is giving people pause, according to an infectious disease specialist….